APEN
APOLLO ENDOSURGERY INC (APEN)
$10.130.6%▲
Market is closedMarket is closed – opens on 8 PM, 01 Dec 2022
– opens on 8 PM, 01 Dec 2022
Key Stats
$10.0
Day's Range
$10.195
$3.49
52-Week Range
$10.3
| Returns | |
| 1 month return | 53.25% |
| 3 month return | 78.66% |
| 1 year return | 25.06% |
| 5 year return | 23.84% |
Company Information
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
| Organization | APOLLO ENDOSURGERY INC |
| Employees | 202 |
| CEO | Mr. Charles S. McKhann |
| Industry | Health Technology |
Analyst Recommendation
based on 5 analysts ratings
Buy
100%
Buy
0%
Hold
0%
Sell
Based on 5 Wall street analysts offering stock ratings for APOLLO ENDOSURGERY INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 24.38%Current
$10.13
Target
$12.6
Recommendation Trend
Based on 5 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 5 | 10 | 11 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 420.1M |
| Book Value | $1.02 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -0.85 |
| PEG Ratio | 0.0 |
| Wall Street Target Price | 12.6 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 5.9 |
| Enterprise Value | 237.0M |
| Enterprise Value/Revenue | 3.3 |
| Enterprise Value/Ebitda | -8.04 |
Technicals
| Beta | 2.28 |
| 50 Day MA | 5.96 |
| 200 Day MA | 5.49 |
Institutional Holdings
Cpmg Inc
9.38%
Nantahala Capital Management, LLC
8.94%
Stonepine Capital Management Llc
5.19%
Archon Capital Management LLC
4.42%
Gagnon Securities LLC
4.29%
Deerfield Management Co
4.2%
Discover more
Frequently Asked Questions
What is APOLLO ENDOSURGERY INC share price today?
Can Indians buy APOLLO ENDOSURGERY INC shares?
How can I buy APOLLO ENDOSURGERY INC shares from India?
Can Fractional shares of APOLLO ENDOSURGERY INC be purchased?
What are the documents required to start investing in APOLLO ENDOSURGERY INC stocks?
What are today’s High and Low prices of APOLLO ENDOSURGERY INC?
What are today’s traded volumes of APOLLO ENDOSURGERY INC?
What is today’s market capitalisation of APOLLO ENDOSURGERY INC?
What is the 52 Week High and Low Range of APOLLO ENDOSURGERY INC?
How much percentage APOLLO ENDOSURGERY INC is down from its 52 Week High?
How much percentage APOLLO ENDOSURGERY INC is up from its 52 Week low?
What are the historical returns of APOLLO ENDOSURGERY INC?
Who is the Chief Executive Officer (CEO) of APOLLO ENDOSURGERY INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*